Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-06-13A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Advancing cancer neuroscience through stress modulation: Interdisciplinary potential of psilocybin and ketamineGeneral Hospital Psychiatry · 2026-02-24Time-Dependent Effects of Rapid-Acting Antidepressants in iPSC-Derived Neurons from Treatment-Resistant Depression and Healthy VolunteersResearch Square · 2026-02-11Wherefore the magic? The evolutionary role of psilocybin in naturebioRxiv · 2025-12-18Taking a Trip into Nature’s Medicine Cabinet: A Country Comparison of Efforts to Reschedule Psilocybin and MDMA for Therapeutic UseeYLS (Yale Law School) · 2025-11-30Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Unknown journal · 2025-11-30The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.Journal of psychoactive drugs · 2025-11-08Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resourcemedRxiv · 2025-08-15Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Mycelium Growth and Development of Psilocybe spp. Mother Cultures on Agar-Based MediaJournal of Fungi · 2025-06-12Pathway engineering for the biosynthesis of psychedelics.Unknown journal · 2025-05-14Race/ethnicity moderates the associations between lifetime psilocybin use and opioid use disorderPLoS ONE · 2025-05-06Psilocybin biosynthesis enhancement through gene source optimizationMetabolic Engineering · 2025-04-1558. Acute Behavioral Effects of Psilocybin and Its Pharmacokinetics in Nonhuman PrimatesBiological Psychiatry · 2025-04-08Age- and estrous-dependent effects of psilocybin in ratsbioRxiv · 2025-01-13Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health ConditionsAmerican Journal of Psychiatry · 2024-12-31Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybinbioRxiv · 2024-12-12Associations between psychedelic use and cannabis use disorder in a nationally representative sample.Unknown journal · 2024-11-13Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey studyJournal of Affective Disorders · 2024-10-21Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertensionFrontiers in Psychiatry · 2024-06-23Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Psilocybin-induced anxiolytic effects supported by transient elevation of corticosteroneJournal of Pharmacology and Experimental Therapeutics · 2024-05-12In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybinFrontiers in Psychiatry · 2024-01-07Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Unknown journal · 2023-08-31Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrestsFrontiers in Psychiatry · 2023-08-23Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in MiceACS Pharmacology & Translational Science · 2023-08-01Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.Unknown journal · 2023-07-18Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trialBJPsych Open · 2023-06-30“Biosynthesis of psilocybin and its nonnatural derivatives by a promiscuous psilocybin synthesis pathway in Escherichia coli”Biotechnology and Bioengineering · 2023-06-19Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Optimizing outcomes in psilocybin therapy: Considerations in participant evaluation and preparationJournal of Affective Disorders · 2023-01-24Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.Journal of Psychopharmacology · 2022-10-30Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.Scientific Reports · 2022-10-09Associations between classic psychedelics and nicotine dependence in a nationally representative sample.Scientific Reports · 2022-06-21Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.Scientific Reports · 2022-04-06Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.Metabolic Engineering Communications · 2022-03-11Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.Scientific Reports · 2022-02-15MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.Journal of Psychopharmacology · 2022-01-04Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.Journal of Psychopharmacology · 2022-01-04The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.Journal of Psychopharmacology · 2022-01-03Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.Journal of Psychopharmacology · 2021-12-31Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?Bioengineered · 2021-11-30Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.Frontiers in Psychiatry · 2021-02-02Psilocybin Can Diminish DepressionThe Primary Care Companion For CNS Disorders · 2020-09-01Psychedelics as a Treatment for Alzheimer's Disease Dementia.Unknown journal · 2020-08-20Delayed Anxiolytic-Like Effects of Psilocybin in Male Mice Are Supported by Acute Glucocorticoid ReleasebioRxiv · 2020-08-13In vivo production of psilocybin in E. coliMetabolic Engineering · 2019-09-20'Magic mushroom' poisoning in a colt.The Veterinary record · 1990-12-14